Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.
about
Role of stereotactic body radiation therapy for hepatocellular carcinomaIdentification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues.Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients.Reduced expression of microRNA‑206 regulates cell proliferation via cyclinD2 in gliomas.Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance.miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtypeUp-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma.Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma.Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma.Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patientsDissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression.Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma.Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.Classifying lower grade glioma cases according to whole genome gene expression.MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapyMolecular prognostic factors in glioblastoma: state of the art and future challenges.Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.RAB34 was a progression- and prognosis-associated biomarker in gliomas.MicroRNAs and cell cycle of malignant glioma.MicroRNA as potential biomarkers in Glioblastoma.IDH1R¹³²H decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a.An update on the epigenetics of glioblastomas.MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.Joint Covariate Detection on Expression Profiles for Selecting Prognostic miRNAs in Glioblastoma.Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.Survival kinase genes present prognostic significance in glioblastoma.
P2860
Q26864969-7AC5060E-E5C6-49D3-BADC-768F7B9BB332Q33584126-60D63644-F602-4D91-8311-52EEAF57500EQ33911224-A6A4DC82-557E-4AC7-95DC-9E74B303C8A5Q34409620-854C4362-7928-4F94-944A-6CEB746ECCE1Q34734182-090842B1-FFDC-4D13-9329-EBBB97C3698BQ35054380-341C6DF6-1330-4079-A39C-BD8A097B39CEQ35121957-2D50B2A0-5FFB-4F42-B623-24F99A776540Q35201676-DE03D064-22EE-46AD-8B7B-BAFAA0F4D7F7Q35376154-0AA2E5A5-A8AC-41E0-B0C4-73AA0795B6BFQ35590879-93B9093F-C1C7-4D0B-94D5-AD66FC02D66BQ35610772-6F3EF4C9-8123-47C6-AC52-4A16B0045366Q35694536-AE9E220F-121F-4B7B-B149-4D43C3510FA3Q35793894-EC477B90-18C0-4230-9A03-4C40A551C1E6Q35854013-38DCCAE6-957C-49DF-A0A8-33A049113CD5Q35919049-848A52F5-F8EB-479A-B30E-F582B6CA45F9Q35964266-DB874052-C6ED-4D80-8481-8046BDDAEFB9Q36046299-4FFE1428-EA23-4098-8A77-29F9456ED054Q36225499-92893036-D335-413C-A7A4-1693B08DF7FAQ36335681-3FF5D43C-999C-4537-95D3-E52F6CD3E9F8Q36546750-C6C5F995-CBFC-45EE-A936-D534D65B06BAQ36557284-0258D030-B59B-49D3-AC43-A9B058CABFACQ37295490-0A10E179-291F-40B7-B4FA-075599D753E8Q37358051-180D3556-3B8B-4370-8342-5512E83A0F85Q37528839-F3F33FF1-DCC4-4625-80F9-EF81E735F4B4Q37567317-12376388-26F8-4FBC-9CF8-C84C19BBBD4AQ37687506-5626601A-D3EC-4788-9AB7-557E3FA724E9Q37687518-90DB8753-7C91-4782-A020-094190764682Q37723702-3EFD1A47-7E61-4F5A-AD8A-9729B21A39ADQ38172970-F9E5EC4F-E69C-4088-9E11-E19B66F5077FQ38233134-E3803BC5-2E36-44A8-9CF2-C322D327AA81Q38439155-FCCF99DA-CFF2-4F2B-A589-9163189FE839Q38469088-0CA43959-70CD-4541-A82B-A92150B7342DQ38497875-FA10F8A8-EB70-4D0F-81D7-39970ABD34A1Q38590626-449923EA-47F0-4FE7-B671-18D447DB3062Q38839229-42849797-676C-49ED-97DF-B13DB769367AQ38944047-8A8E9ABD-A317-4EBB-8E69-AA7FE8301313Q39523091-B0620E18-5BB3-46BA-86F1-2C42C3C1C2D9Q40242716-133090E0-C332-4D0A-8094-E5823EACADA1Q41135067-D6DD1314-9730-41B8-B770-93B2EF29D508Q41535101-DC8895C6-612C-4F99-807E-B051763DB704
P2860
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Whole-genome microRNA expressi ...... imary glioblastoma multiforme.
@en
Whole-genome microRNA expressi ...... imary glioblastoma multiforme.
@nl
type
label
Whole-genome microRNA expressi ...... imary glioblastoma multiforme.
@en
Whole-genome microRNA expressi ...... imary glioblastoma multiforme.
@nl
prefLabel
Whole-genome microRNA expressi ...... imary glioblastoma multiforme.
@en
Whole-genome microRNA expressi ...... imary glioblastoma multiforme.
@nl
P2093
P2860
P921
P356
P1433
P1476
Whole-genome microRNA expressi ...... imary glioblastoma multiforme.
@en
P2093
Chuanlu Jiang
Chunsheng Kang
Clark C Chen
Shouwei Li
Sonya Wei Song
Yongping You
P2860
P304
P356
10.1002/CNCR.27826
P407
P50
P577
2012-09-18T00:00:00Z